Rana Al-Hrout/LinkedIn
Nov 7, 2026, 11:37
Rana Al-Hrout: ITP Treatment in 2026 – Moving Beyond Platelet Counts
Rana Al-Hrout, Clinical Pathology-Hematology Specialist at Ministry of Health – Jordan, shared a post on LinkedIn:
“The Evolving ITP Treatment Landscape – 2026
The management of Immune Thrombocytopenia (ITP) continues to evolve toward more individualized and patient-centered treatment strategies.
Key developments include:
- Corticosteroids: Emphasis on short treatment courses and minimizing long-term exposure.
- Combination therapy: Earlier consideration of TPO-receptor agonists and Rituximab in selected patients.
- Targeted therapies: Expanding treatment options, including SYK and BTK inhibitors.
- Patient-centered care: Focusing on bleeding prevention, treatment burden, and quality of life.
The key message:
Successful ITP management goes beyond platelet counts. It aims for sustainable disease control and improved patient outcomes.”
Other posts featuring Rana Al-Hrout on Hemostatis Today.
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights
-
Nov 7, 2026, 12:06Kinza Raza: Giving Back Through Thalassaemia Awareness – A Journey Back to School